5631 - 5640 of 7939 Results
Title
Year
- White Matter Tract Alterations in Drug-Naïve Parkinson’s Disease Patients With Impulse Control Disorders2018OPENTitle: White Matter Tract Alterations in Drug-Naïve Parkinson’s Disease Patients With Impulse Control DisordersJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 9Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2018.00163Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2018.00163/pdfCitation Count: 23
-
OPENTitle: A comparison of publicly available linear MRI stereotaxic registration techniquesJournal Name: NeuroImagePublisher: Elsevier BVVol: 174Issue #:Start Page: 191End Page: 200Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuroimage.2018.03.025Best OA location URL: http://escholarship.mcgill.ca/downloads/jq085r32sCitation Count: 137
-
OPENTitle: Progression of regional grey matter atrophy in multiple sclerosisJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 141Issue #: 6Start Page: 1665End Page: 1677Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/brain/awy088Best OA location URL: https://academic.oup.com/brain/article-pdf/141/6/1665/25083373/awy088.pdfCitation Count: 307
- Atrophy in the Thalamus But Not Cerebellum Is Specific for C9orf72 FTD and ALS Patients – An Atlas-Based Volumetric MRI Study2018OPENTitle: Atrophy in the Thalamus But Not Cerebellum Is Specific for C9orf72 FTD and ALS Patients – An Atlas-Based Volumetric MRI StudyJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 10Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2018.00045Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2018.00045/pdfCitation Count: 44
-
OPENTitle: Glucagon‐like Peptides (GLP‐1) Perspectives in Synucleinopathies TreatmentJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 5Issue #: 3Start Page: 255End Page: 258Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12611Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12611Citation Count: 7
-
RESTRICTEDTitle: Initial cognitive changes in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 4Start Page: 511End Page: 519Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27330Best OA location URL: https://europepmc.org/articles/pmc5920539?pdf=renderCitation Count: 44
-
OPENTitle: Tau oligomers mediate α-synuclein toxicity and can be targeted by immunotherapyJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-018-0245-9Best OA location URL: https://doi.org/10.1186/s13024-018-0245-9Citation Count: 62
-
OPENTitle: The Effect of Obesity on the Availabilities of Dopamine and Serotonin TransportersJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-018-22814-8Best OA location URL: https://www.nature.com/articles/s41598-018-22814-8.pdfCitation Count: 39
- M1-positive allosteric modulators lacking agonist activity provide the optimal profile for enhancing cognition2018OPENTitle: M1-positive allosteric modulators lacking agonist activity provide the optimal profile for enhancing cognitionJournal Name: NeuropsychopharmacologyPublisher: Springer Science and Business Media LLCVol: 43Issue #: 8Start Page: 1763End Page: 1771Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41386-018-0033-9Best OA location URL: https://www.nature.com/articles/s41386-018-0033-9.pdfCitation Count: 62
-
OPENTitle: Pilot Single-Blind Trial of AbobotulinumtoxinA in Oromandibular DystoniaJournal Name: NeurotherapeuticsPublisher: Elsevier BVVol: 15Issue #: 2Start Page: 452End Page: 458Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s13311-018-0620-9Best OA location URL: https://link.springer.com/content/pdf/10.1007/s13311-018-0620-9.pdfCitation Count: 10